The role of liver iron in hepatitis C antiviral treatment.
Musallam
Khaled M
KM
Sharara
Ala I
AI
Inati
Adlete
A
Taher
Ali T
AT
D000755:Anemia, Sickle Cell / Q000150:complications* / Q000628:therapy; D000998:Antiviral Agents / Q000627:therapeutic use*; D001803:Blood Transfusion; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D007501:Iron / Q000032:analysis / Q000378:metabolism*; D008099:Liver / Q000378:metabolism*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*; D017086:beta-Thalassemia / Q000150:complications* / Q000628:therapy
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; D007501:Iron; C100416:peginterferon alfa-2a